Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Barbarano L"'
Autor:
Corso, A., Mangiacavalli, S., Barbarano, L., Montalbetti, L., Mazzone, A., Fava, S., Varettoni, M., Zappasodi, P., Morra, E., Lazzarino, M.
Publikováno v:
In Leukemia Research 2008 32(7):1085-1090
Autor:
Riccardi, A, Mora, O, Tinelli, C, Porta, C, Danova, M, Brugnatelli, S, Grasso, D, Tolcà, B, Spanedda, R, De Paoli, A, Barbarano, L, Cavanna, L, Giordano, M, Delfini, C, Nicoletti, G, Bergonzi, C, Rinaldi, E, Piccinini, L, Ascari, E
Publikováno v:
In European Journal of Cancer 2003 39(1):31-37
Autor:
Corso A, Mangiacavalli S, Barbarano L, Alessandrino EP, Cairoli R, Morra E, Lazzarino M, Host Group
Publikováno v:
Cancer. 109(11)
BACKGROUND. Although high-dose therapy is considered the standard therapy for younger patients with multiple myeloma (MM), the advantages of performing a second transplant remain debated. The current study was conducted to evaluate the efficacy and t
Autor:
Brugnatelli, S., Riccardi, A., Ucci, G., Mora, O., Barbarano, L., Piva, N., Piccinini, L., Bergonzi, C., De Paoli, A., Di Stasi, M., Rinaldi, E., Trotti, G., Petrini, M., Ascari, E.
Publikováno v:
British Journal of Cancer
In a multicentre study, 83 patients with advanced and previously uniformly treated multiple myeloma (MM) were randomised between cyclophosphamide (600 mg m-2) and epirubicin (70 mg m-2), administered every 3 weeks for three courses and both associate
Autor:
Annamaria Nosari, Alessandra Tedeschi, Gargantini L, Paola Marenco, Enrica Morra, Elisabetta Tresoldi, Giovanni Grillo, Roberto Cairoli, Barbarano L
Publikováno v:
Bone marrow transplantation. 29(6)
The aim of our study was to evaluate the impact of an early intensification programme including chemotherapy (CHT), autologous stem cell transplantation (ASCT) and radiation therapy (RT) in patients with primary mediastinal large B cell lymphoma (MLC
Autor:
G Pinotti, G Frigerio, Alessandro Corso, M. Lazzarino, L Isa, L. Uziel, S. Fava, S. Montanara, G Ucci, A Vismara, Enrica Morra, Emilio Paolo Alessandrino, M Fiumanò, F Rodeghiero, Alberto Santagostino, Barbarano L, M Savarè, A Luraschi, Roberto Cairoli, D Perego, D. Ferrari, S Morandi
DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) has proved to be an effective salvage therapy for refractory-relapsed MM patients. Little is known, however, about its potential as mobilizing therapy. The aim of this study was to eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::564f6671a1085ffa3b07e231acc4c2f3
https://hdl.handle.net/10281/408703
https://hdl.handle.net/10281/408703
Autor:
Riccardi, A., Ucci, G., Luoni, R., Brugnatelli, S., Mora, O., Spanedda, R., De Paoli, A., Barbarano, L., Di Stasi, M., Alberio, F.
Publikováno v:
British Journal of Cancer
The purpose of the study was to ascertain whether the prognostic significance of staging in multiple myeloma (MM) is influenced by the aggressiveness of effective induction treatment and/or by continuing or discontinuing maintenance chemotherapy. Pat
Autor:
Riccardi, A., Mora, O., Tinelli, C., Valentini, D., Brugnatelli, S., Spanedda, R., De Paoli, A., Barbarano, L., Di Stasi, M., Giordano, M., Delfini, C., Nicoletti, G., Bergonzi, C., Rinaldi, E., Piccinini, Lino, Ascari, E.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3674::68be98599a739de4eb9ccd5b7ae232ce
https://hdl.handle.net/11380/310703
https://hdl.handle.net/11380/310703